TrialAmerican journal of clinical oncology2012

Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical Trial.

Steven Robert Alberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.